Global Radiotherapy

Radiotherapy Comprehensive Study by Type (External Beam Radiotherapy (IMRT, IGRT, Others), Internal Beam Radiotherapy (LDR, HDR, PDR), Systemic Radiotherapy), Application (Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Others), End User (Hospitals, Independent Radiotherapy Centers), Type (External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others), Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products), Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186)) Players and Region - Global Market Outlook to 2029

Radiotherapy Market by XX Submarkets | Forecast Years 2024-2029  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The incidence of cancer is increasing, particularly because of the increase in life expectancy arising from worldwide improvements in standards of living. Radiation therapy or radiotherapy is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor (for example, early stages of breast cancer). Radiation therapy is synergistic with chemotherapy and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. According to the research estimates of the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO), approximately ten million new cases of cancer are being detected per year worldwide

AttributesDetails
Study Period2019-2029
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledVarian Medical Systems, Inc. (United States), Elekta (Sweden), Accuray Incorporated (United States), Ion Beam Applications SA (Belgium), ViewRay, Inc. (United States), IsoRay Medical, Inc. (United States), Hitachi Ltd. (Japan) and Panacea Medical Technologies Pvt. Ltd. (India)


This growth is primarily driven by Growing global cancer burden and Surging healthcare expenditure are some of the chief growth-inducing factors in the radiotherapy market.

Globally, a noticeable market trend is evident The growing Adoption of Pencil-Beam Scanning Major Players, such as Varian Medical Systems, Inc. (United States), Elekta (Sweden), Accuray Incorporated (United States), Ion Beam Applications SA (Belgium), ViewRay, Inc. (United States), IsoRay Medical, Inc. (United States), Hitachi Ltd. (Japan) and Panacea Medical Technologies Pvt. Ltd. (India), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Key Developments in the Market:
In May 2019 Varian Medical Systems United States-based company acquired Cancer Treatment Services International for USD 283. This transaction will accelerate the identification of unmet clinical and operational needs to facilitate advances in technology and services. As a result, the combined companies will be positioned to create new multidisciplinary solutions based on robust clinical information benefiting oncologists, and ultimately resulting in better care for patients.
In September 2020 Elekta Sweden Based company introduced its new radiotherapy solution to help address the worldwide cancer burden named Elekta Harmony linear accelerator (linac) intended to treat or meet the need of the health care centers and for a productive, precise, and versatile radiotherapy treatment system.

Regulatory Insights:
“To establish a Radiotherapy facility, the user institute must go through the Regulatory requirements as mentioned in the Atomic Energy (Radiation Protection) Rules, 2004 and AERB Safety Codes [AERB/RF-SC/MED-1(Rev. 1)] and shall obtain requisite regulatory consent from AERB as per AERB Safety Guide for Consenting process for Radiation Facilities (AERB/RF/SG/G-3). No regulatory clearance is issued for establishing the radiotherapy facility by AERB unless the user complies with the regulatory requirements”

Influencing Trend:
The growing Adoption of Pencil-Beam Scanning

Market Growth Drivers:
Growing global cancer burden and Surging healthcare expenditure are some of the chief growth-inducing factors in the radiotherapy market

Challenges:
Risk of Radiation Exposure

Restraints:
Affordability and Accessibility of Treatment

Opportunities:
Increasing cancer occurring in developing countries and Increasing healthcare expenditure are some of the chief growth-inducing factors in the radiotherapy market

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Radiotherapy Market
- Analysis about New Entrants in Radiotherapy Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Radiotherapy Study Sheds Light on
— The Radiotherapy Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Radiotherapy industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Radiotherapy industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • External Beam Radiotherapy (IMRT, IGRT, Others)
  • Internal Beam Radiotherapy (LDR, HDR, PDR)
  • Systemic Radiotherapy
By Application
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Colorectal Cancer
  • Others
By End User
  • Hospitals
  • Independent Radiotherapy Centers

By Type
  • External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others)
  • Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products)
  • Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing global cancer burden
      • 3.2.2. Surging healthcare expenditure are some of the chief growth-inducing factors in the radiotherapy market
    • 3.3. Market Challenges
      • 3.3.1. Risk of Radiation Exposure
    • 3.4. Market Trends
      • 3.4.1. The growing Adoption of Pencil-Beam Scanning
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Radiotherapy, by Type, Application, End User , Type and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Radiotherapy (Value)
      • 5.2.1. Global Radiotherapy by: Type (Value)
        • 5.2.1.1. External Beam Radiotherapy (IMRT, IGRT, Others)
        • 5.2.1.2. Internal Beam Radiotherapy (LDR, HDR, PDR)
        • 5.2.1.3. Systemic Radiotherapy
      • 5.2.2. Global Radiotherapy by: Type (Value)
        • 5.2.2.1. External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others)
        • 5.2.2.2. Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products)
        • 5.2.2.3. Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186)
      • 5.2.3. Global Radiotherapy by: Application (Value)
        • 5.2.3.1. Prostate Cancer
        • 5.2.3.2. Breast Cancer
        • 5.2.3.3. Lung Cancer
        • 5.2.3.4. Head & Neck Cancer
        • 5.2.3.5. Colorectal Cancer
        • 5.2.3.6. Others
      • 5.2.4. Global Radiotherapy by: Type (Value)
        • 5.2.4.1. External Beam Radiotherapy (IMRT, IGRT, Others)
        • 5.2.4.2. Internal Beam Radiotherapy (LDR, HDR, PDR)
        • 5.2.4.3. Systemic Radiotherapy
      • 5.2.5. Global Radiotherapy by: Type (Value)
        • 5.2.5.1. External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others)
        • 5.2.5.2. Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products)
        • 5.2.5.3. Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186)
      • 5.2.6. Global Radiotherapy Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Radiotherapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Varian Medical Systems, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Elekta (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Accuray Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ion Beam Applications SA (Belgium)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ViewRay, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. IsoRay Medical, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hitachi Ltd. (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Panacea Medical Technologies Pvt. Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Radiotherapy Sale, by Type, Application, End User , Type and Region (value) (2024-2029)
    • 7.1. Introduction
    • 7.2. Global Radiotherapy (Value)
      • 7.2.1. Global Radiotherapy by: Type (Value)
        • 7.2.1.1. External Beam Radiotherapy (IMRT, IGRT, Others)
        • 7.2.1.2. Internal Beam Radiotherapy (LDR, HDR, PDR)
        • 7.2.1.3. Systemic Radiotherapy
      • 7.2.2. Global Radiotherapy by: Type (Value)
        • 7.2.2.1. External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others)
        • 7.2.2.2. Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products)
        • 7.2.2.3. Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186)
      • 7.2.3. Global Radiotherapy by: Application (Value)
        • 7.2.3.1. Prostate Cancer
        • 7.2.3.2. Breast Cancer
        • 7.2.3.3. Lung Cancer
        • 7.2.3.4. Head & Neck Cancer
        • 7.2.3.5. Colorectal Cancer
        • 7.2.3.6. Others
      • 7.2.4. Global Radiotherapy by: Type (Value)
        • 7.2.4.1. External Beam Radiotherapy (IMRT, IGRT, Others)
        • 7.2.4.2. Internal Beam Radiotherapy (LDR, HDR, PDR)
        • 7.2.4.3. Systemic Radiotherapy
      • 7.2.5. Global Radiotherapy by: Type (Value)
        • 7.2.5.1. External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others)
        • 7.2.5.2. Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products)
        • 7.2.5.3. Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186)
      • 7.2.6. Global Radiotherapy Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Radiotherapy: by Type(USD Million)
  • Table 2. Radiotherapy External Beam Radiotherapy (IMRT, IGRT, Others) , by Region USD Million (2018-2023)
  • Table 3. Radiotherapy Internal Beam Radiotherapy (LDR, HDR, PDR) , by Region USD Million (2018-2023)
  • Table 4. Radiotherapy Systemic Radiotherapy , by Region USD Million (2018-2023)
  • Table 5. Radiotherapy: by Type(USD Million)
  • Table 6. Radiotherapy External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others) , by Region USD Million (2018-2023)
  • Table 7. Radiotherapy Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products) , by Region USD Million (2018-2023)
  • Table 8. Radiotherapy Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186) , by Region USD Million (2018-2023)
  • Table 9. Radiotherapy: by Application(USD Million)
  • Table 10. Radiotherapy Prostate Cancer , by Region USD Million (2018-2023)
  • Table 11. Radiotherapy Breast Cancer , by Region USD Million (2018-2023)
  • Table 12. Radiotherapy Lung Cancer , by Region USD Million (2018-2023)
  • Table 13. Radiotherapy Head & Neck Cancer , by Region USD Million (2018-2023)
  • Table 14. Radiotherapy Colorectal Cancer , by Region USD Million (2018-2023)
  • Table 15. Radiotherapy Others , by Region USD Million (2018-2023)
  • Table 16. Radiotherapy: by Type(USD Million)
  • Table 17. Radiotherapy External Beam Radiotherapy (IMRT, IGRT, Others) , by Region USD Million (2018-2023)
  • Table 18. Radiotherapy Internal Beam Radiotherapy (LDR, HDR, PDR) , by Region USD Million (2018-2023)
  • Table 19. Radiotherapy Systemic Radiotherapy , by Region USD Million (2018-2023)
  • Table 20. Radiotherapy: by Type(USD Million)
  • Table 21. Radiotherapy External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others) , by Region USD Million (2018-2023)
  • Table 22. Radiotherapy Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products) , by Region USD Million (2018-2023)
  • Table 23. Radiotherapy Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186) , by Region USD Million (2018-2023)
  • Table 24. South America Radiotherapy, by Country USD Million (2018-2023)
  • Table 25. South America Radiotherapy, by Type USD Million (2018-2023)
  • Table 26. South America Radiotherapy, by Application USD Million (2018-2023)
  • Table 27. South America Radiotherapy, by End User USD Million (2018-2023)
  • Table 28. South America Radiotherapy, by Type USD Million (2018-2023)
  • Table 29. Brazil Radiotherapy, by Type USD Million (2018-2023)
  • Table 30. Brazil Radiotherapy, by Application USD Million (2018-2023)
  • Table 31. Brazil Radiotherapy, by End User USD Million (2018-2023)
  • Table 32. Brazil Radiotherapy, by Type USD Million (2018-2023)
  • Table 33. Argentina Radiotherapy, by Type USD Million (2018-2023)
  • Table 34. Argentina Radiotherapy, by Application USD Million (2018-2023)
  • Table 35. Argentina Radiotherapy, by End User USD Million (2018-2023)
  • Table 36. Argentina Radiotherapy, by Type USD Million (2018-2023)
  • Table 37. Rest of South America Radiotherapy, by Type USD Million (2018-2023)
  • Table 38. Rest of South America Radiotherapy, by Application USD Million (2018-2023)
  • Table 39. Rest of South America Radiotherapy, by End User USD Million (2018-2023)
  • Table 40. Rest of South America Radiotherapy, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Radiotherapy, by Country USD Million (2018-2023)
  • Table 42. Asia Pacific Radiotherapy, by Type USD Million (2018-2023)
  • Table 43. Asia Pacific Radiotherapy, by Application USD Million (2018-2023)
  • Table 44. Asia Pacific Radiotherapy, by End User USD Million (2018-2023)
  • Table 45. Asia Pacific Radiotherapy, by Type USD Million (2018-2023)
  • Table 46. China Radiotherapy, by Type USD Million (2018-2023)
  • Table 47. China Radiotherapy, by Application USD Million (2018-2023)
  • Table 48. China Radiotherapy, by End User USD Million (2018-2023)
  • Table 49. China Radiotherapy, by Type USD Million (2018-2023)
  • Table 50. Japan Radiotherapy, by Type USD Million (2018-2023)
  • Table 51. Japan Radiotherapy, by Application USD Million (2018-2023)
  • Table 52. Japan Radiotherapy, by End User USD Million (2018-2023)
  • Table 53. Japan Radiotherapy, by Type USD Million (2018-2023)
  • Table 54. India Radiotherapy, by Type USD Million (2018-2023)
  • Table 55. India Radiotherapy, by Application USD Million (2018-2023)
  • Table 56. India Radiotherapy, by End User USD Million (2018-2023)
  • Table 57. India Radiotherapy, by Type USD Million (2018-2023)
  • Table 58. South Korea Radiotherapy, by Type USD Million (2018-2023)
  • Table 59. South Korea Radiotherapy, by Application USD Million (2018-2023)
  • Table 60. South Korea Radiotherapy, by End User USD Million (2018-2023)
  • Table 61. South Korea Radiotherapy, by Type USD Million (2018-2023)
  • Table 62. Taiwan Radiotherapy, by Type USD Million (2018-2023)
  • Table 63. Taiwan Radiotherapy, by Application USD Million (2018-2023)
  • Table 64. Taiwan Radiotherapy, by End User USD Million (2018-2023)
  • Table 65. Taiwan Radiotherapy, by Type USD Million (2018-2023)
  • Table 66. Australia Radiotherapy, by Type USD Million (2018-2023)
  • Table 67. Australia Radiotherapy, by Application USD Million (2018-2023)
  • Table 68. Australia Radiotherapy, by End User USD Million (2018-2023)
  • Table 69. Australia Radiotherapy, by Type USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Radiotherapy, by Type USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Radiotherapy, by Application USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Radiotherapy, by End User USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Radiotherapy, by Type USD Million (2018-2023)
  • Table 74. Europe Radiotherapy, by Country USD Million (2018-2023)
  • Table 75. Europe Radiotherapy, by Type USD Million (2018-2023)
  • Table 76. Europe Radiotherapy, by Application USD Million (2018-2023)
  • Table 77. Europe Radiotherapy, by End User USD Million (2018-2023)
  • Table 78. Europe Radiotherapy, by Type USD Million (2018-2023)
  • Table 79. Germany Radiotherapy, by Type USD Million (2018-2023)
  • Table 80. Germany Radiotherapy, by Application USD Million (2018-2023)
  • Table 81. Germany Radiotherapy, by End User USD Million (2018-2023)
  • Table 82. Germany Radiotherapy, by Type USD Million (2018-2023)
  • Table 83. France Radiotherapy, by Type USD Million (2018-2023)
  • Table 84. France Radiotherapy, by Application USD Million (2018-2023)
  • Table 85. France Radiotherapy, by End User USD Million (2018-2023)
  • Table 86. France Radiotherapy, by Type USD Million (2018-2023)
  • Table 87. Italy Radiotherapy, by Type USD Million (2018-2023)
  • Table 88. Italy Radiotherapy, by Application USD Million (2018-2023)
  • Table 89. Italy Radiotherapy, by End User USD Million (2018-2023)
  • Table 90. Italy Radiotherapy, by Type USD Million (2018-2023)
  • Table 91. United Kingdom Radiotherapy, by Type USD Million (2018-2023)
  • Table 92. United Kingdom Radiotherapy, by Application USD Million (2018-2023)
  • Table 93. United Kingdom Radiotherapy, by End User USD Million (2018-2023)
  • Table 94. United Kingdom Radiotherapy, by Type USD Million (2018-2023)
  • Table 95. Netherlands Radiotherapy, by Type USD Million (2018-2023)
  • Table 96. Netherlands Radiotherapy, by Application USD Million (2018-2023)
  • Table 97. Netherlands Radiotherapy, by End User USD Million (2018-2023)
  • Table 98. Netherlands Radiotherapy, by Type USD Million (2018-2023)
  • Table 99. Rest of Europe Radiotherapy, by Type USD Million (2018-2023)
  • Table 100. Rest of Europe Radiotherapy, by Application USD Million (2018-2023)
  • Table 101. Rest of Europe Radiotherapy, by End User USD Million (2018-2023)
  • Table 102. Rest of Europe Radiotherapy, by Type USD Million (2018-2023)
  • Table 103. MEA Radiotherapy, by Country USD Million (2018-2023)
  • Table 104. MEA Radiotherapy, by Type USD Million (2018-2023)
  • Table 105. MEA Radiotherapy, by Application USD Million (2018-2023)
  • Table 106. MEA Radiotherapy, by End User USD Million (2018-2023)
  • Table 107. MEA Radiotherapy, by Type USD Million (2018-2023)
  • Table 108. Middle East Radiotherapy, by Type USD Million (2018-2023)
  • Table 109. Middle East Radiotherapy, by Application USD Million (2018-2023)
  • Table 110. Middle East Radiotherapy, by End User USD Million (2018-2023)
  • Table 111. Middle East Radiotherapy, by Type USD Million (2018-2023)
  • Table 112. Africa Radiotherapy, by Type USD Million (2018-2023)
  • Table 113. Africa Radiotherapy, by Application USD Million (2018-2023)
  • Table 114. Africa Radiotherapy, by End User USD Million (2018-2023)
  • Table 115. Africa Radiotherapy, by Type USD Million (2018-2023)
  • Table 116. North America Radiotherapy, by Country USD Million (2018-2023)
  • Table 117. North America Radiotherapy, by Type USD Million (2018-2023)
  • Table 118. North America Radiotherapy, by Application USD Million (2018-2023)
  • Table 119. North America Radiotherapy, by End User USD Million (2018-2023)
  • Table 120. North America Radiotherapy, by Type USD Million (2018-2023)
  • Table 121. United States Radiotherapy, by Type USD Million (2018-2023)
  • Table 122. United States Radiotherapy, by Application USD Million (2018-2023)
  • Table 123. United States Radiotherapy, by End User USD Million (2018-2023)
  • Table 124. United States Radiotherapy, by Type USD Million (2018-2023)
  • Table 125. Canada Radiotherapy, by Type USD Million (2018-2023)
  • Table 126. Canada Radiotherapy, by Application USD Million (2018-2023)
  • Table 127. Canada Radiotherapy, by End User USD Million (2018-2023)
  • Table 128. Canada Radiotherapy, by Type USD Million (2018-2023)
  • Table 129. Mexico Radiotherapy, by Type USD Million (2018-2023)
  • Table 130. Mexico Radiotherapy, by Application USD Million (2018-2023)
  • Table 131. Mexico Radiotherapy, by End User USD Million (2018-2023)
  • Table 132. Mexico Radiotherapy, by Type USD Million (2018-2023)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Radiotherapy: by Type(USD Million)
  • Table 142. Radiotherapy External Beam Radiotherapy (IMRT, IGRT, Others) , by Region USD Million (2024-2029)
  • Table 143. Radiotherapy Internal Beam Radiotherapy (LDR, HDR, PDR) , by Region USD Million (2024-2029)
  • Table 144. Radiotherapy Systemic Radiotherapy , by Region USD Million (2024-2029)
  • Table 145. Radiotherapy: by Type(USD Million)
  • Table 146. Radiotherapy External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others) , by Region USD Million (2024-2029)
  • Table 147. Radiotherapy Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products) , by Region USD Million (2024-2029)
  • Table 148. Radiotherapy Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186) , by Region USD Million (2024-2029)
  • Table 149. Radiotherapy: by Application(USD Million)
  • Table 150. Radiotherapy Prostate Cancer , by Region USD Million (2024-2029)
  • Table 151. Radiotherapy Breast Cancer , by Region USD Million (2024-2029)
  • Table 152. Radiotherapy Lung Cancer , by Region USD Million (2024-2029)
  • Table 153. Radiotherapy Head & Neck Cancer , by Region USD Million (2024-2029)
  • Table 154. Radiotherapy Colorectal Cancer , by Region USD Million (2024-2029)
  • Table 155. Radiotherapy Others , by Region USD Million (2024-2029)
  • Table 156. Radiotherapy: by Type(USD Million)
  • Table 157. Radiotherapy External Beam Radiotherapy (IMRT, IGRT, Others) , by Region USD Million (2024-2029)
  • Table 158. Radiotherapy Internal Beam Radiotherapy (LDR, HDR, PDR) , by Region USD Million (2024-2029)
  • Table 159. Radiotherapy Systemic Radiotherapy , by Region USD Million (2024-2029)
  • Table 160. Radiotherapy: by Type(USD Million)
  • Table 161. Radiotherapy External Beam Radiotherapy Products (LINAC, Cobalt-60 LINAC, others) , by Region USD Million (2024-2029)
  • Table 162. Radiotherapy Internal Beam Radiotherapy/Brachytherapy Products(Seeds, Applicators, Afterloader, Electronic Brachytherapy Products) , by Region USD Million (2024-2029)
  • Table 163. Radiotherapy Systemic Radiotherapy (Iobenguane-131, Samarium-153, Rhenium-186) , by Region USD Million (2024-2029)
  • Table 164. South America Radiotherapy, by Country USD Million (2024-2029)
  • Table 165. South America Radiotherapy, by Type USD Million (2024-2029)
  • Table 166. South America Radiotherapy, by Application USD Million (2024-2029)
  • Table 167. South America Radiotherapy, by End User USD Million (2024-2029)
  • Table 168. South America Radiotherapy, by Type USD Million (2024-2029)
  • Table 169. Brazil Radiotherapy, by Type USD Million (2024-2029)
  • Table 170. Brazil Radiotherapy, by Application USD Million (2024-2029)
  • Table 171. Brazil Radiotherapy, by End User USD Million (2024-2029)
  • Table 172. Brazil Radiotherapy, by Type USD Million (2024-2029)
  • Table 173. Argentina Radiotherapy, by Type USD Million (2024-2029)
  • Table 174. Argentina Radiotherapy, by Application USD Million (2024-2029)
  • Table 175. Argentina Radiotherapy, by End User USD Million (2024-2029)
  • Table 176. Argentina Radiotherapy, by Type USD Million (2024-2029)
  • Table 177. Rest of South America Radiotherapy, by Type USD Million (2024-2029)
  • Table 178. Rest of South America Radiotherapy, by Application USD Million (2024-2029)
  • Table 179. Rest of South America Radiotherapy, by End User USD Million (2024-2029)
  • Table 180. Rest of South America Radiotherapy, by Type USD Million (2024-2029)
  • Table 181. Asia Pacific Radiotherapy, by Country USD Million (2024-2029)
  • Table 182. Asia Pacific Radiotherapy, by Type USD Million (2024-2029)
  • Table 183. Asia Pacific Radiotherapy, by Application USD Million (2024-2029)
  • Table 184. Asia Pacific Radiotherapy, by End User USD Million (2024-2029)
  • Table 185. Asia Pacific Radiotherapy, by Type USD Million (2024-2029)
  • Table 186. China Radiotherapy, by Type USD Million (2024-2029)
  • Table 187. China Radiotherapy, by Application USD Million (2024-2029)
  • Table 188. China Radiotherapy, by End User USD Million (2024-2029)
  • Table 189. China Radiotherapy, by Type USD Million (2024-2029)
  • Table 190. Japan Radiotherapy, by Type USD Million (2024-2029)
  • Table 191. Japan Radiotherapy, by Application USD Million (2024-2029)
  • Table 192. Japan Radiotherapy, by End User USD Million (2024-2029)
  • Table 193. Japan Radiotherapy, by Type USD Million (2024-2029)
  • Table 194. India Radiotherapy, by Type USD Million (2024-2029)
  • Table 195. India Radiotherapy, by Application USD Million (2024-2029)
  • Table 196. India Radiotherapy, by End User USD Million (2024-2029)
  • Table 197. India Radiotherapy, by Type USD Million (2024-2029)
  • Table 198. South Korea Radiotherapy, by Type USD Million (2024-2029)
  • Table 199. South Korea Radiotherapy, by Application USD Million (2024-2029)
  • Table 200. South Korea Radiotherapy, by End User USD Million (2024-2029)
  • Table 201. South Korea Radiotherapy, by Type USD Million (2024-2029)
  • Table 202. Taiwan Radiotherapy, by Type USD Million (2024-2029)
  • Table 203. Taiwan Radiotherapy, by Application USD Million (2024-2029)
  • Table 204. Taiwan Radiotherapy, by End User USD Million (2024-2029)
  • Table 205. Taiwan Radiotherapy, by Type USD Million (2024-2029)
  • Table 206. Australia Radiotherapy, by Type USD Million (2024-2029)
  • Table 207. Australia Radiotherapy, by Application USD Million (2024-2029)
  • Table 208. Australia Radiotherapy, by End User USD Million (2024-2029)
  • Table 209. Australia Radiotherapy, by Type USD Million (2024-2029)
  • Table 210. Rest of Asia-Pacific Radiotherapy, by Type USD Million (2024-2029)
  • Table 211. Rest of Asia-Pacific Radiotherapy, by Application USD Million (2024-2029)
  • Table 212. Rest of Asia-Pacific Radiotherapy, by End User USD Million (2024-2029)
  • Table 213. Rest of Asia-Pacific Radiotherapy, by Type USD Million (2024-2029)
  • Table 214. Europe Radiotherapy, by Country USD Million (2024-2029)
  • Table 215. Europe Radiotherapy, by Type USD Million (2024-2029)
  • Table 216. Europe Radiotherapy, by Application USD Million (2024-2029)
  • Table 217. Europe Radiotherapy, by End User USD Million (2024-2029)
  • Table 218. Europe Radiotherapy, by Type USD Million (2024-2029)
  • Table 219. Germany Radiotherapy, by Type USD Million (2024-2029)
  • Table 220. Germany Radiotherapy, by Application USD Million (2024-2029)
  • Table 221. Germany Radiotherapy, by End User USD Million (2024-2029)
  • Table 222. Germany Radiotherapy, by Type USD Million (2024-2029)
  • Table 223. France Radiotherapy, by Type USD Million (2024-2029)
  • Table 224. France Radiotherapy, by Application USD Million (2024-2029)
  • Table 225. France Radiotherapy, by End User USD Million (2024-2029)
  • Table 226. France Radiotherapy, by Type USD Million (2024-2029)
  • Table 227. Italy Radiotherapy, by Type USD Million (2024-2029)
  • Table 228. Italy Radiotherapy, by Application USD Million (2024-2029)
  • Table 229. Italy Radiotherapy, by End User USD Million (2024-2029)
  • Table 230. Italy Radiotherapy, by Type USD Million (2024-2029)
  • Table 231. United Kingdom Radiotherapy, by Type USD Million (2024-2029)
  • Table 232. United Kingdom Radiotherapy, by Application USD Million (2024-2029)
  • Table 233. United Kingdom Radiotherapy, by End User USD Million (2024-2029)
  • Table 234. United Kingdom Radiotherapy, by Type USD Million (2024-2029)
  • Table 235. Netherlands Radiotherapy, by Type USD Million (2024-2029)
  • Table 236. Netherlands Radiotherapy, by Application USD Million (2024-2029)
  • Table 237. Netherlands Radiotherapy, by End User USD Million (2024-2029)
  • Table 238. Netherlands Radiotherapy, by Type USD Million (2024-2029)
  • Table 239. Rest of Europe Radiotherapy, by Type USD Million (2024-2029)
  • Table 240. Rest of Europe Radiotherapy, by Application USD Million (2024-2029)
  • Table 241. Rest of Europe Radiotherapy, by End User USD Million (2024-2029)
  • Table 242. Rest of Europe Radiotherapy, by Type USD Million (2024-2029)
  • Table 243. MEA Radiotherapy, by Country USD Million (2024-2029)
  • Table 244. MEA Radiotherapy, by Type USD Million (2024-2029)
  • Table 245. MEA Radiotherapy, by Application USD Million (2024-2029)
  • Table 246. MEA Radiotherapy, by End User USD Million (2024-2029)
  • Table 247. MEA Radiotherapy, by Type USD Million (2024-2029)
  • Table 248. Middle East Radiotherapy, by Type USD Million (2024-2029)
  • Table 249. Middle East Radiotherapy, by Application USD Million (2024-2029)
  • Table 250. Middle East Radiotherapy, by End User USD Million (2024-2029)
  • Table 251. Middle East Radiotherapy, by Type USD Million (2024-2029)
  • Table 252. Africa Radiotherapy, by Type USD Million (2024-2029)
  • Table 253. Africa Radiotherapy, by Application USD Million (2024-2029)
  • Table 254. Africa Radiotherapy, by End User USD Million (2024-2029)
  • Table 255. Africa Radiotherapy, by Type USD Million (2024-2029)
  • Table 256. North America Radiotherapy, by Country USD Million (2024-2029)
  • Table 257. North America Radiotherapy, by Type USD Million (2024-2029)
  • Table 258. North America Radiotherapy, by Application USD Million (2024-2029)
  • Table 259. North America Radiotherapy, by End User USD Million (2024-2029)
  • Table 260. North America Radiotherapy, by Type USD Million (2024-2029)
  • Table 261. United States Radiotherapy, by Type USD Million (2024-2029)
  • Table 262. United States Radiotherapy, by Application USD Million (2024-2029)
  • Table 263. United States Radiotherapy, by End User USD Million (2024-2029)
  • Table 264. United States Radiotherapy, by Type USD Million (2024-2029)
  • Table 265. Canada Radiotherapy, by Type USD Million (2024-2029)
  • Table 266. Canada Radiotherapy, by Application USD Million (2024-2029)
  • Table 267. Canada Radiotherapy, by End User USD Million (2024-2029)
  • Table 268. Canada Radiotherapy, by Type USD Million (2024-2029)
  • Table 269. Mexico Radiotherapy, by Type USD Million (2024-2029)
  • Table 270. Mexico Radiotherapy, by Application USD Million (2024-2029)
  • Table 271. Mexico Radiotherapy, by End User USD Million (2024-2029)
  • Table 272. Mexico Radiotherapy, by Type USD Million (2024-2029)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Radiotherapy: by Type USD Million (2018-2023)
  • Figure 5. Global Radiotherapy: by Type USD Million (2018-2023)
  • Figure 6. Global Radiotherapy: by Application USD Million (2018-2023)
  • Figure 7. Global Radiotherapy: by Type USD Million (2018-2023)
  • Figure 8. Global Radiotherapy: by Type USD Million (2018-2023)
  • Figure 9. South America Radiotherapy Share (%), by Country
  • Figure 10. Asia Pacific Radiotherapy Share (%), by Country
  • Figure 11. Europe Radiotherapy Share (%), by Country
  • Figure 12. MEA Radiotherapy Share (%), by Country
  • Figure 13. North America Radiotherapy Share (%), by Country
  • Figure 14. Global Radiotherapy share by Players 2023 (%)
  • Figure 15. Global Radiotherapy share by Players (Top 3) 2023(%)
  • Figure 16. Global Radiotherapy share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Elekta (Sweden) Revenue, Net Income and Gross profit
  • Figure 21. Elekta (Sweden) Revenue: by Geography 2023
  • Figure 22. Accuray Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 23. Accuray Incorporated (United States) Revenue: by Geography 2023
  • Figure 24. Ion Beam Applications SA (Belgium) Revenue, Net Income and Gross profit
  • Figure 25. Ion Beam Applications SA (Belgium) Revenue: by Geography 2023
  • Figure 26. ViewRay, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. ViewRay, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. IsoRay Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. IsoRay Medical, Inc. (United States) Revenue: by Geography 2023
  • Figure 30. Hitachi Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 31. Hitachi Ltd. (Japan) Revenue: by Geography 2023
  • Figure 32. Panacea Medical Technologies Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 33. Panacea Medical Technologies Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 34. Global Radiotherapy: by Type USD Million (2024-2029)
  • Figure 35. Global Radiotherapy: by Type USD Million (2024-2029)
  • Figure 36. Global Radiotherapy: by Application USD Million (2024-2029)
  • Figure 37. Global Radiotherapy: by Type USD Million (2024-2029)
  • Figure 38. Global Radiotherapy: by Type USD Million (2024-2029)
  • Figure 39. South America Radiotherapy Share (%), by Country
  • Figure 40. Asia Pacific Radiotherapy Share (%), by Country
  • Figure 41. Europe Radiotherapy Share (%), by Country
  • Figure 42. MEA Radiotherapy Share (%), by Country
  • Figure 43. North America Radiotherapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Varian Medical Systems, Inc. (United States)
  • Elekta (Sweden)
  • Accuray Incorporated (United States)
  • Ion Beam Applications SA (Belgium)
  • ViewRay, Inc. (United States)
  • IsoRay Medical, Inc. (United States)
  • Hitachi Ltd. (Japan)
  • Panacea Medical Technologies Pvt. Ltd. (India)
Additional players considered in the study are as follows:
Provision Healthcare (United States) , Mevion Medical Systems, Inc. (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 200 Pages 76 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Radiotherapy Quantitative research analysis
Global Radiotherapy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Radiotherapy market are Varian Medical Systems, Inc. (United States), Elekta (Sweden), Accuray Incorporated (United States), Ion Beam Applications SA (Belgium), ViewRay, Inc. (United States), IsoRay Medical, Inc. (United States), Hitachi Ltd. (Japan) and Panacea Medical Technologies Pvt. Ltd. (India), to name a few.
is dominating the Radiotherapy Market.
"Risk of Radiation Exposure" is seen as one of the major challenges by many Industry Players of Radiotherapy Market
The Radiotherapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Radiotherapy market is expected to see a steady growth rate during projected year 2023 to 2029.

Know More About Global Radiotherapy Report?

Have a Query? Click Here

Other Related Reports

Autism Spectrum Disorder Comprehensive Study by Type (Applied Behavior Analysis, Discrete Trial Teaching, Pivotal Response Treatment), Indication (Insomnia, Epilepsy, Depression, Hyperactivity & Inat...
$ 3450
Blood Serum Comprehensive Study by Type (Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine), Equine, Porcine, Other), Application (Cell Culture Media, Cell Line Saving, Tissue Culture, Diagnosti...
$ 3500
Pigmented Lesion Treatment Comprehensive Study by Type (Energy Based Devices, RF Devices, Ultrasound Devices, IPL Devices), Application (Dermatology Clinics, Beauty Clinics, Hospitals), Treatment (La...
$ 3650
Stretch Marks Treatment Comprehensive Study by Type (Topical Products (Oils, Creams, and Lotion), Lasers (Pulse-Dye Laser, Fractional Laser, and Others), Microdermabrasion, Others), Application (Hosp...
$ 3450
Animal Genetics Comprehensive Study by Type (Live Animals), Application (Genetic Typing, Genetic Trait Testing, Genetic Disease Testing), Genetic Testing (DNA Testing, DNA Typing, Genetic Disease Tes...
$ 3650
Botulism Treatment Comprehensive Study by Type (Antitoxin, Antibiotics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), End User (Hospitals, Specialty Clinics, Others), Bo...
$ 3450